Andrew Williams Joins as Financial Controller

Andrew Williams has joined as Financial Controller. With a talent for financial analysis and interpretation, Andrew commits to a rigorous, accurate, and systematic approach.

Prior to NATROX®, he worked for tech companies including Linguamatics, who make a language processing AI platform for healthcare and pharma, and Cambridge Antibody Technology, a biotech company headquartered in Cambridge who became part of AstraZeneca in a £702M acquisition. Andrew has also worked at several prestigious educational institutions including the University of Cambridge, and Cambridge Education Group.

Andrew received his M.A. from the University of Cambridge and is recognised for his skills in Due Diligence, Strategy, and Forecasting.